Article metrics
PDF
Other content recommended for you
- Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis
- Different expression patterns of LGALS1 and LGALS3 in polycythemia vera, essential thrombocythemia and primary myelofibrosis
- Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations
- Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation
- Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings
- Vertebral artery thrombosis: a rare presentation of primary polycythaemia
- Sagittal sinus thrombosis in JAK2-V617F mutation without overt myeloproliferative disorder
- Essential thrombocythemia in a young man treated for myocardial infarction
- Off-pump coronary artery surgery in a patient with essential thrombocythaemia: two life-threatening complications in the same patient
- Molecular genetic tests for JAK2V617F, Exon12_JAK2 and MPLW515K/L are highly informative in the evaluation of patients suspected to have BCR-ABL1-negative myeloproliferative neoplasms